نتایج جستجو برای: bladder tumor

تعداد نتایج: 476571  

غفوری, سحر, مختاری, دکتر غلامرضا, ناظمی, دکتر علی,

Abstract Introduction: Genetic variation of FGFR3 gene is one of the factors affecting the bladder tumor. FGFR3 is a tyrosine kinase receptor, involved in controlling the cellular and angiogenesis cycle. This protein affects a variety of diseases and cancers and cartilage growth abnormalities. Regarding the high activity of fgfr3 mutations in more than 50% of primary tumors of bladder urethral...

خوشحال, ‌فیروز, فلاحتکار, دکتر سیاوش, نوبخت, الهوردی,

ABSTRACT In this study, 100 patients with negative labaratory test and without definitive diagnosis by imaging ,were evaluated by cystoscopy. Hematuria was defined as the appearance of red blood cells equali to or more than two in high power field (hpf). ¼ of these patients had microscopic hematuria and ¾ of patients had macroscopic hematuria. Male to female ratio increases significantly wi...

Journal: :Open Journal of Urology 2023

Urothelial Carcinoma (UC) is one of the most frequent cancers worldwide. Transurethral Resection Bladder Tumor (TURBT) a standard treatment in disease’s early stages, with bladder perforation being possible and classical complication. However, extravesical tumor seeding resulting from rare phenomenon. We hereby report case 76-year-old man history smoking diagnosed high-grade T1 urothelial carci...

ابراهیمی, مژگان, عسگری, مژگان , فرشیدپور, مینو ,

Cancer of the bladder comprises 5.2% of all malignancies and it is the fifth common malignancy in Iran. Transitional cell carcinoma represents 92% of all bladder tumors. Voided urine cytology and cystoscopic biopsy are used for screening and final diagnosis respectively in Iran. Selection of the therapy is according to the tumor grade which is detected by bladder biopsy. The hypothesi...

دهقانی, دکتر ولی اله, معین, دکتر محمدرضا,

Diagnostic Value of Fibrin/Fibrinogen Degradation Products and its Comparsion with Urine Cytology in the Diagnosis of Bladder Carcinoma M.R. Moein MD , V. Dehghani MD Received: 16/06/06 Sent for Revision: 01/11/06 Received Revised Manuscript: 05/02/07 Accepted: 12/03/07 Background and Objective: The bladder tumar is common in urinary system and its certain diagnostic method is cystos...

The treatment of bladder cancer is usually performed by Bacillus Calmette-Guerin (BCG) instillation. BCG therapy is a common therapeutic method with fewer side effects compared with chemotherapy, radiotherapy, etc. BCG can also inhibit the progression and recurrence of bladder cancer by inducing apoptosis pathways, arrest cell cycle, autophagy, and neutrophil extracellular traps (NETs) formatio...

Journal: :modares journal of medical sciences: pathobiology 2007
nazila nourae ardalan ozhand mahmoud parvin amir mohsen ziaee nasim hatefi

objective: inhibition of apoptosis may favor the onset and progression of cancer. survivin is an inhibitor of apoptosis that has been considered as a potential marker for diagnostic and/or prognostic of bladder cancer. the survivin protein regulates both cell division and cell death and is overexpressed in the vast majority of human cancers. in this study, the expression pattern and potential p...

Background: Bladder cancer accounts for about 7% of all cancers among adults in Iran. We aimed to evaluate epidemiological and clinicopathological features of bladder cancer in Kermanshah province, west Iran. Methods: In a descriptive retrospective study, records of patients with bladder cancer referring to Imam Reza Hospital, Kermanshah city, Iran during 2011-2013 were analyzed. Sex, age, smo...

احمدی, علی, الفتی, گلرخ, مرادی تبریز, هدیه, نیکی, فرزانه,

Background: Transitional Cell Carcinoma (TCC) is the most common type of urinary bladder cancer. Cyclooxygenase-2 (COX-2), a key enzyme in prostaglandins biosynthesis, has been introduced as a new candidate for targeted therapy in this cancer. In this study, we investigated the expression of COX-2 in urinary bladder TCCs and its relationship with clinicopathological parameters such as tumor gra...

Journal: :iranian journal of blood and cancer 0
mazaher ramezani department of pathology, imam reza hospital, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) nima naderi department of pathology, imam reza hospital, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) afshin almasi department of biostatistics and epidemiology, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) masoud sadeghi cancer research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences)

background: bladder cancer accounts for about 7% of all cancers among adults in iran. we aimed to evaluate epidemiological and clinicopathological features of bladder cancer in kermanshah province, west iran. methods: in a descriptive retrospective study, records of patients with bladder cancer referring to imam reza hospital, kermanshah city, iran during 2011-2013 were analyzed. sex, age, smok...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید